Cited by 15Drug Transport and Resistance MechanismsProtein Structure and DynamicsComputational Drug Discovery Methods

Insights into the structure and function of the human organic anion transporter 1 in lipid bilayer membranes

Open access
Janaszkiewicz, Angelika, Tóth, Ágota, Faucher, Quentin, Martin, Marving, Chantemargue, Benjamin, Barin-Le Guellec, Chantal, Marquet, Pierre, Di Meo, Florent·2022·Scientific Reports

Published version of a preprint

Abstract

The human SLC22A6/OAT1 plays an important role in the elimination of a broad range of endogenous substances and xenobiotics thus attracting attention from the pharmacological community. Furthermore, OAT1 is also involved in key physiological events such as the remote inter-organ communication. Despite its significance, the knowledge about h OAT1 structure and the transport mechanism at the atomic level remains fragmented owing to the lack of resolved structures. By means of protein-threading modeling refined by μs-scaled Molecular Dynamics simulations, the present study provides the first robust model of h OAT1 in outward-facing conformation. Taking advantage of the AlphaFold 2 predicted structure of h OAT1 in inward-facing conformation, we here provide the essential structural and functional features comparing both states. The intracellular motifs conserved among Major Facilitator Superfamily members create a so-called “charge-relay system” that works as molecular switches modulating the conformation. The principal element of the event points at interactions of charged residues that appear crucial for the transporter dynamics and function. Moreover, h OAT1 model was embedded in different lipid bilayer membranes highlighting the crucial structural dependence on lipid-protein interactions. MD simulations supported the pivotal role of phosphatidylethanolamine components to the protein conformation stability. The present model is made available to decipher the impact of any observed polymorphism and mutation on drug transport as well as to understand substrate binding modes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-022-10755-2

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Janaszkiewicz, A., Tóth, Á., Faucher, Q., Martin, M., Chantemargue, B., Barin-Le Guellec, C., Marquet, P., & Di Meo, F.
Affiliations
  • Inserm (FR)
  • Université de Limoges (FR)
Venue
Scientific Reports
Published
2022-04-29
Volume
12
Issue
1
Pages
7057-7057
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4225246974
Cited by
15
References
2
Citations by year
2026: 3 · 2025: 1 · 2024: 4 · 2023: 7
FWCI
1.26
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Funders
  • Agence Nationale de la Recherche (ANR-19-CE17-0020-01 IMOTEP)
  • Région Nouvelle-Aquitaine, France (AAP-NA-2019-VICTOR)
  • Institut National de la Santé et de la Recherche Médicale
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
Keywords
SLC22A6, OAT1, major facilitator superfamily, charge relay system, protein-lipid interactions, phosphatidylethanolamine, membrane protein structure, protein threading, drug transport, xenobiotic removal
MeSH terms
Biological Transport, Humans, Lipid Bilayers, Protein Conformation, Organic Anion Transporters, Organic Anion Transport Protein 1, Molecular Dynamics Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review